Found: 5
Select item for more details and to access through your institution.
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 2, p. 1, doi. 10.1177/2055217318765288
- By:
- Publication type:
- Article
Feasibility of mesenchymal stem cell culture expansion for a phase I clinical trial in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2018, v. 4, n. 1, p. 1, doi. 10.1177/2055217318765288
- By:
- Publication type:
- Article
Cotransduction with MGMT and Ubiquitous or Erythroid-Specific GFP Lentiviruses Allows Enrichment of Dual-Positive Hematopoietic Progenitor Cells In Vivo.
- Published in:
- ISRN Hematology, 2012, p. 1, doi. 10.5402/2012/212586
- By:
- Publication type:
- Article
Limited Lentiviral Transgene Expression with Increasing Copy Number in an MGMT Selection Model: Lack of Copy Number Selection by Drug Treatment
- Published in:
- Molecular Therapy, 2004, v. 9, n. 6, p. 923, doi. 10.1016/j.ymthe.2004.02.017
- By:
- Publication type:
- Article
Myeloablation is not required to select and maintain expression of the drug-resistance gene, mutant MGMT, in primary and secondary recipients
- Published in:
- Molecular Therapy, 2003, v. 8, n. 1, p. 42, doi. 10.1016/S1525-0016(03)00141-2
- By:
- Publication type:
- Article